Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus

66Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The enteropathogenic coronavirus transmissible gastroenteritis virus (TGEV) causes severe disease in young piglets. We have studied the protective effects of the probiotic Enterococcus faecium NCIMB 10415 (E. faecium), which is approved as a feed additive in the European Union, against TGEV infection. E. faecium was added to swine testicle (ST) cells before, concomitantly with, or after TGEV infection. Viability assays revealed that E. faecium led to a dose-dependent rescue of viability of TGEV-infected cells reaching nearly to complete protection. Virus yields of the E. faecium-treated cultures were reduced by up to three log10 units. Western blot analysis of purified TGEV revealed that the levels of all viral structural proteins were reduced after E. faecium treatment. Using transmission electron microscopy, we observed attachment of TGEV particles to the surface of E. faecium which might be a means to trap virus and to prevent infection. Increased production of nitric oxide in the cells treated with E. faecium and elevated expression of interleukin 6 and 8 pointed to stimulated cellular defense as a mechanism to fight TGEV infection. © 2012 Springer-Verlag Wien.

Cite

CITATION STYLE

APA

Chai, W., Burwinkel, M., Wang, Z., Palissa, C., Esch, B., Twardziok, S., … Schmidt, M. F. G. (2013). Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Archives of Virology, 158(4), 799–807. https://doi.org/10.1007/s00705-012-1543-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free